Abstract
ObjectiveTo examine the relative effectiveness of a fourth dose of the Pfizer-BioNTech mRNA (BNT162b2) vaccine compared with three vaccine doses over the span of 10 weeks.DesignRetrospective, test negative, case-control study,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have